488 related articles for article (PubMed ID: 19058920)
21. Whole-breast radiotherapy with shorter fractionation schedules following breast-conserving surgery: short-term morbidity and preliminary outcomes.
Fujii O; Hiratsuka J; Nagase N; Tokiya R; Yoden E; Sonoo H; Murashima N; Iha S; Imajyo Y
Breast Cancer; 2008; 15(1):86-92. PubMed ID: 18224401
[TBL] [Abstract][Full Text] [Related]
22. Computed tomography (CT) scan evaluation of late toxicity following hypofractionated/accelerated radiotherapy with cytoprotection (HypoARC) in breast cancer patients treated with conservative surgery.
Manavis J; Ambatzoglou J; Sismanidou K; Koukourakis MI
Am J Clin Oncol; 2006 Oct; 29(5):479-83. PubMed ID: 17023783
[TBL] [Abstract][Full Text] [Related]
23. Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients.
Ortholan C; Hannoun-Lévi JM; Ferrero JM; Largillier R; Courdi A
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):154-62. PubMed ID: 15629606
[TBL] [Abstract][Full Text] [Related]
24. Cosmesis, late sequelae and local control after breast-conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy.
Budrukkar AN; Sarin R; Shrivastava SK; Deshpande DD; Dinshaw KA
Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):596-603. PubMed ID: 17706403
[TBL] [Abstract][Full Text] [Related]
25. Accelerated partial breast irradiation with iridium-192 multicatheter PDR/HDR brachytherapy. Preliminary results of the German-Austrian multicenter trial.
Ott OJ; Pötter R; Hammer J; Hildebrandt G; Lotter M; Resch A; Pöhls U; Beckmann MW; Sauer R; Strnad V
Strahlenther Onkol; 2004 Oct; 180(10):642-9. PubMed ID: 15480513
[TBL] [Abstract][Full Text] [Related]
26. Preliminary data of the GORTEC 2000-02 phase III trial comparing intravenous and subcutaneous administration of amifostine for head and neck tumors treated by external radiotherapy.
Bardet E; Martin L; Calais G; Tuchais C; Bourhis J; Rhein B; Feham N; Alphonsi M
Semin Oncol; 2002 Dec; 29(6 Suppl 19):57-60. PubMed ID: 12577246
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis.
McDonald MW; Godette KD; Butker EK; Davis LW; Johnstone PA
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1031-40. PubMed ID: 18440727
[TBL] [Abstract][Full Text] [Related]
28. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441
[TBL] [Abstract][Full Text] [Related]
29. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
[TBL] [Abstract][Full Text] [Related]
30. Dose escalation of amifostine for radioprotection during pelvic accelerated radiotherapy.
Koukourakis MI; Kyrgias G; Panteliadou M; Papadopoulou A; Tsiarkatsi M; Papachristou E; Bebeli M
Am J Clin Oncol; 2013 Aug; 36(4):338-43. PubMed ID: 22643562
[TBL] [Abstract][Full Text] [Related]
31. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.
Lemanski C; Azria D; Thezenas S; Gutowski M; Saint-Aubert B; Rouanet P; Fenoglietto P; Ailleres N; Dubois JB
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1410-5. PubMed ID: 16442241
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of subcutaneous amifostine in minimizing radiation-induced toxicities in patients receiving combined-modality treatment for squamous cell carcinoma of the head and neck.
Law A; Kennedy T; Pellitteri P; Wood C; Christie D; Yumen O
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1361-8. PubMed ID: 17869022
[TBL] [Abstract][Full Text] [Related]
33. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy.
Harsolia A; Kestin L; Grills I; Wallace M; Jolly S; Jones C; Lala M; Martinez A; Schell S; Vicini FA
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1375-80. PubMed ID: 17544598
[TBL] [Abstract][Full Text] [Related]
34. Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience.
Mussari S; Sabino Della Sala W; Busana L; Vanoni V; Eccher C; Zani B; Menegotti L; Tomio L
Strahlenther Onkol; 2006 Oct; 182(10):589-95. PubMed ID: 17013572
[TBL] [Abstract][Full Text] [Related]
35. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17.
Kuske RR; Winter K; Arthur DW; Bolton J; Rabinovitch R; White J; Hanson W; Wilenzick RM
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):45-51. PubMed ID: 16503383
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcome with interstitial brachytherapy boost in the treatment of women with early-stage breast cancer.
Neumanova R; Petera J; Frgala T; Dusek L; Jarkovsky J; Kuricka R
Neoplasma; 2007; 54(5):413-23. PubMed ID: 17688371
[TBL] [Abstract][Full Text] [Related]
37. Radiotherapy after segmental resection of breast cancer with favorable prognostic features: 12-year follow-up results of a randomized trial.
Holli K; Hietanen P; Saaristo R; Huhtala H; Hakama M; Joensuu H
J Clin Oncol; 2009 Feb; 27(6):927-32. PubMed ID: 19114687
[TBL] [Abstract][Full Text] [Related]
38. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
[TBL] [Abstract][Full Text] [Related]
39. Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer.
Anné PR
Semin Oncol; 2002 Dec; 29(6 Suppl 19):80-3. PubMed ID: 12577250
[TBL] [Abstract][Full Text] [Related]
40. Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy.
Kirova YM; Campana F; Savignoni A; Laki F; Muresan M; Dendale R; Bollet MA; Salmon RJ; Fourquet A;
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):76-81. PubMed ID: 19168297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
